| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 6SN82Y9U73 |
| InChI Key | WEIAMZKHBCLFOG-QPAIBFMUSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C11H15ClN4O4 |
| Molecular Weight | 302.72 |
| AlogP | -2.02 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 6.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 134.26 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 19.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Purine nucleoside phosphorylase inhibitor | PubMed |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | D015451 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
| Leukemia, Lymphoid | 1 | D007945 | ClinicalTrials |
| Lymphoma, T-Cell, Peripheral | 1 | D016411 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL550755 |
| EPA CompTox | DTXSID90182647 |
| FDA SRS | 6SN82Y9U73 |
| SureChEMBL | SCHEMBL1949526 |